Yi Du
Impact in
- Oncology top 2%
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Pickering emulsions and particle stabilization 15
- Co-authors
- Mien‐Chie Hung (19 shared papers)Weiya Xia (11 shared papers)Hirohito Yamaguchi (11 shared papers)Jennifer L. Hsu (10 shared papers)Yongkun Wei (6 shared papers)Jung-Mao Hsu (6 shared papers)Chao‐Kai Chou (5 shared papers)Chia‐Wei Li (3 shared papers)
- Journals
- Molecular Cancer Therapeutics (3 papers)Polymers for Advanced Technologies (3 papers)Cancer Research (3 papers)Oncogene (3 papers)Journal of Biological Chemistry (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Yi Du
67 papers receiving 3.8k citations
Yi Du's Hit Papers
Peers
Comparison fields: 5 of 141
- Oncology 1.3k
- Cancer Research 599
- Surfaces, Coatings and Films 258
- Molecular Biology 1.7k
- Immunology 429
Countries citing papers authored by Yi Du
This map shows the geographic impact of Yi Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Du more than expected).
Fields of papers citing papers by Yi Du
This network shows the impact of papers produced by Yi Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Du. The network helps show where Yi Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression Hit paper breakdown → | 2017 | 787 |
| 2 | 2009 | 338 | |
| 3 | 2013 | 294 | |
| 4 | 2010 | 241 | |
| 5 | 2007 | 204 | |
| 6 | 2019 | 161 | |
| 7 | 2008 | 122 | |
| 8 | 2013 | 110 | |
| 9 | 2010 | 100 | |
| 10 | 2017 | 85 | |
| 11 | 2010 | 77 | |
| 12 | 2011 | 77 | |
| 13 | 2012 | 75 | |
| 14 | 2015 | 70 | |
| 15 | 2012 | 62 | |
| 16 | 2023 | 62 | |
| 17 | 2018 | 61 | |
| 18 | 2010 | 59 | |
| 19 | 2010 | 55 | |
| 20 | 2004 | 49 |
About Yi Du
Yi Du is a scholar working on Molecular Biology, Materials Chemistry, Oncology, Cancer Research and Organic Chemistry, having authored 68 papers that have together received 3.8k indexed citations. Recurring topics across this work include Pickering emulsions and particle stabilization (15 papers), Advanced Polymer Synthesis and Characterization (12 papers), Cancer-related Molecular Pathways (6 papers), Surface Modification and Superhydrophobicity (5 papers), Innovative Microfluidic and Catalytic Techniques Innovation (5 papers), Cancer-related molecular mechanisms research (5 papers), NF-κB Signaling Pathways (5 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (599 citations), Surfaces, Coatings and Films (258 citations), Molecular Biology (1.7k citations) and Immunology (429 citations). Yi Du has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Mien‐Chie Hung, Weiya Xia, Hirohito Yamaguchi, Jennifer L. Hsu, Yongkun Wei, Jung-Mao Hsu, Chao‐Kai Chou, Chia‐Wei Li, Heng‐Huan Lee and Gabriel N. Hortobágyi. Their work appears in journals such as Molecular Cancer Therapeutics, Polymers for Advanced Technologies, Cancer Research, Oncogene and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.